Carol Meeske

H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers

M. Warmuth, Shouyong Peng, O. Abdel-Wahab, 2018, Nature Medicine.

H3B-8800, an Orally Bioavailable Modulator of the SF3b Complex, Shows Efficacy in Spliceosome-Mutant Myeloid Malignancies

M. Warmuth, O. Abdel-Wahab, B. Caleb, 2016 .

Experimental Therapeutics, Molecular Targets, and Chemical Biology De novo Discovery of a γ-Secretase Inhibitor Response Signature Using a Novel In vivo Breast Tumor Model

P. Majumder, J. Watters, C. Winter, 2009 .

Experimental Therapeutics, Molecular Targets, and Chemical Biology De novo Discovery of a γ-Secretase Inhibitor Response Signature Using a Novel In vivo Breast Tumor Model

P. Majumder, J. Watters, C. Winter, 2009 .

H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers

M. Warmuth, Shouyong Peng, O. Abdel-Wahab, 2018, Nature Medicine.